Literature DB >> 25346582

Iron Oxide Hyperthermia And Radiation Cancer Treatment.

Sm Cassim1, Aj Giustini2, Aa Petryk1, Ra Strawbridge3, Pj Hoopes2.   

Abstract

It is established that heat can enhance the effect of radiation cancer treatment. Due to the ability to localize thermal energy using nanoparticle hyperthermia, as opposed to other, less targeted, hyperthermia modalities, it appears such enhancement could be accomplished without complications normally associated with systemic or regional hyperthermia. This study employs non-curative (suboptimal), doses of heat and radiation, in an effort to determine the therapeutic enhancement potential for IONP hyperthermia and radiation.
METHODS: MTG-B murine breast adenocarcinoma cell are inoculated into the right flanks of female CH3/HEJ mice and grown to volumes of 150mm3 +/- 40 mm3. A single dose of 15 Gy (6 MeV) radiation was uniformly delivered to the tumor. A pre-defined thermal dose is delivered by direct injection of iron oxide nanoparticles into the tumor. By adjusting the field strength of the 160 KHz alternating magnetic field (AMF) an intra-tumoral temperature between 41.5 and 43 degrees Celsius was maintained for 10min. The alternating magnetic field was delivered by a water-cooled 36mm diameter square copper tube induction coil operating at 160 kHz with variable magnet field strengths up to 450 Oe. The primary endpoint of the study is the number of days required for the tumor to achieve a volume 3 fold greater than the volume at the time of treatment (tumor regrowth delay).
RESULTS: Preliminary results suggest the addition of a modest IONP hyperthermia to 15 Gy radiation achieved an approximate 50% increase in tumor regrowth delay as compared to a 15 Gy radiation treatment alone. The therapeutic effects of IONP heat and radiation combined were considered additive, however in mice that demonstrated complete response (no tumor present after 30 days), the effect was considered superadditive or synergistic. Although this data is very encouraging from a multimodality cancer therapy standpoint, additional temporal and dose related information is clearly necessary to optimize the therapy.

Entities:  

Keywords:  AMF; HT-29; Iron oxide; MTG-B; TEM; adenocarcinoma; murine; nanoparticle; transmission electron microscopy

Year:  2009        PMID: 25346582      PMCID: PMC4208073          DOI: 10.1117/12.810035

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  20 in total

1.  Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group.

Authors:  C C Vernon; J W Hand; S B Field; D Machin; J B Whaley; J van der Zee; W L van Putten; G C van Rhoon; J D van Dijk; D González González; F F Liu; P Goodman; M Sherar
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-07-01       Impact factor: 7.038

2.  Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer.

Authors:  Manfred Johannsen; Burghard Thiesen; Uwe Gneveckow; Kasra Taymoorian; Norbert Waldöfner; Regina Scholz; Serdar Deger; Klaus Jung; Stefan A Loening; Andreas Jordan
Journal:  Prostate       Date:  2006-01-01       Impact factor: 4.104

3.  Cell killing and the sequencing of hyperthermia and radiation.

Authors:  S A Sapareto; G P Raaphorst; W C Dewey
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-03       Impact factor: 7.038

4.  Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia.

Authors:  A Jordan; P Wust; H Fähling; W John; A Hinz; R Felix
Journal:  Int J Hyperthermia       Date:  1993 Jan-Feb       Impact factor: 3.914

5.  Implication of blood flow in hyperthermic treatment of tumors.

Authors:  C W Song; A Lokshina; J G Rhee; M Patten; S H Levitt
Journal:  IEEE Trans Biomed Eng       Date:  1984-01       Impact factor: 4.538

6.  Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

Authors:  P K Sneed; P R Stauffer; M W McDermott; C J Diederich; K R Lamborn; M D Prados; S Chang; K A Weaver; L Spry; M K Malec; S A Lamb; B Voss; R L Davis; W M Wara; D A Larson; T L Phillips; P H Gutin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-15       Impact factor: 7.038

7.  Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro.

Authors:  A Jordan; P Wust; R Scholz; B Tesche; H Fähling; T Mitrovics; T Vogl; J Cervós-Navarro; R Felix
Journal:  Int J Hyperthermia       Date:  1996 Nov-Dec       Impact factor: 3.914

8.  Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients.

Authors:  R Valdagni; M Amichetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-01-01       Impact factor: 7.038

Review 9.  The cellular and molecular basis of hyperthermia.

Authors:  Bert Hildebrandt; Peter Wust; Olaf Ahlers; Annette Dieing; Geetha Sreenivasa; Thoralf Kerner; Roland Felix; Hanno Riess
Journal:  Crit Rev Oncol Hematol       Date:  2002-07       Impact factor: 6.312

10.  Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer: a preliminary report.

Authors:  John A Kalapurakal; Margaret Pierce; Alan Chen; Vythialingam Sathiaseelan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-01       Impact factor: 7.038

View more
  15 in total

1.  Mitigation of eddy current heating during magnetic nanoparticle hyperthermia therapy.

Authors:  Robert V Stigliano; Fridon Shubitidze; James D Petryk; Levan Shoshiashvili; Alicia A Petryk; P Jack Hoopes
Journal:  Int J Hyperthermia       Date:  2016-07-20       Impact factor: 3.914

2.  Effect of intra-tumoral magnetic nanoparticle hyperthermia and viral nanoparticle immunogenicity on primary and metastatic cancer.

Authors:  P Jack Hoopes; Courtney M Mazur; Bjorn Osterberg; Ailin Song; David J Gladstone; Nicole F Steinmetz; Frank A Veliz; Alicea A Bursey; Robert J Wagner; Steven N Fiering
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-02-20

3.  Hypo-fractionated Radiation, Magnetic Nanoparticle Hyperthermia and a Viral Immunotherapy Treatment of Spontaneous Canine Cancer.

Authors:  P Jack Hoopes; Karen L Moodie; Alicia A Petryk; James D Petryk; Shawntel Sechrist; David J Gladstone; Nicole F Steinmetz; Frank A Veliz; Alicea A Bursey; Robert J Wagner; Ashish Rajan; Danielle Dugat; Margaret Crary-Burney; Steven N Fiering
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-02-22

4.  The effect of hypofractionated radiation and magnetic nanoparticle hyperthermia on tumor immunogenicity and overall treatment response.

Authors:  P Jack Hoopes; Robert J Wagner; Ailin Song; Bjorn Osterberg; David J Gladstone; Alicea A Bursey; Steven N Fiering; Andrew J Giustini
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-02-23

5.  Numerical Model Study of In Vivo Magnetic Nanoparticle Tumor Heating.

Authors:  John A Pearce; Alicia A Petryk; P Jack Hoopes
Journal:  IEEE Trans Biomed Eng       Date:  2017-03-01       Impact factor: 4.538

6.  Kinetics and pathogenesis of intracellular magnetic nanoparticle cytotoxicity.

Authors:  Andrew J Giustini; Rachel E Gottesman; A A Petryk; A M Rauwerdink; P Jack Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2011-02-10

7.  Magnetic Heating of Nanoparticles: The Importance of Particle Clustering to Achieve Therapeutic Temperatures.

Authors:  John Pearce; Andrew Giustini; Robert Stigliano; P Jack Hoopes
Journal:  J Nanotechnol Eng Med       Date:  2013-07-16

8.  MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT.

Authors:  Andrew J Giustini; Alicia A Petryk; Shiraz M Cassim; Jennifer A Tate; Ian Baker; P Jack Hoopes
Journal:  Nano Life       Date:  2010-03

9.  Understanding mNP Hyperthermia for cancer treatment at the cellular scale.

Authors:  Robert V Stigliano; Fridon Shubitidze; Katsiaryna Kekalo; Ian Baker; Andrew J Giustini; P Jack Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-02-26

10.  Imaging and modification of the tumor vascular barrier for improvement in magnetic nanoparticle uptake and hyperthermia treatment efficacy.

Authors:  P Jack Hoopes; Alicia A Petryk; Jennifer A Tate; Mark S Savellano; Rendall R Strawbridge; Andrew J Giustini; Radu V Stan; Barjor Gimi; Michael Garwood
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.